An2 Therapeutics Inc

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$5.16

+0.18 (+3.61%)

As of Jun 24, 5:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +259.5% upside

Low Target $11.23

Average Target $18.55

High Target $22.80

Current Price $5.16

Current
$5.16

Target
$18.55

$11.23 $18.55 avg $22.80

Scenario Analysis

Bear Case

$11.23

117.6%

Low target

Base Case

$18.55

+259.5%

Avg target

Bull Case

$22.80

+341.9%

High target

Risk/Reward

2.9x

Favorable

Price in Context

52-Week High

$6.91

-25.3% from high

52-Week Low

$1.00

+416.0% from low

Target vs 52W High

$18.55

+168.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+19.4%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+24.7%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+31.4%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+40.7%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+168.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%